Sarepta Therapeutics (SRPT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to -$851.0 million.
- Sarepta Therapeutics' Enterprise Value rose 2898.67% to -$851.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$851.0 million, marking a year-over-year increase of 2898.67%. This contributed to the annual value of -$1.4 billion for FY2024, which is 4828.58% up from last year.
- Sarepta Therapeutics' Enterprise Value amounted to -$851.0 million in Q3 2025, which was up 2898.67% from -$963.0 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Enterprise Value registered a high of -$851.0 million during Q3 2025, and its lowest value of -$2.6 billion during Q4 2023.
- In the last 5 years, Sarepta Therapeutics' Enterprise Value had a median value of -$1.7 billion in 2023 and averaged -$1.7 billion.
- In the last 5 years, Sarepta Therapeutics' Enterprise Value tumbled by 3168.8% in 2023 and then surged by 4828.58% in 2024.
- Quarter analysis of 5 years shows Sarepta Therapeutics' Enterprise Value stood at -$2.1 billion in 2021, then increased by 5.98% to -$2.0 billion in 2022, then crashed by 31.69% to -$2.6 billion in 2023, then skyrocketed by 48.29% to -$1.4 billion in 2024, then soared by 37.18% to -$851.0 million in 2025.
- Its Enterprise Value was -$851.0 million in Q3 2025, compared to -$963.0 million in Q2 2025 and -$894.2 million in Q1 2025.